首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1733621

全球核子造影設備市場－按產品、應用、最終用戶、地區、預測的市場規模

Global Nuclear Imaging Equipment Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月14日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

核子造影設備市場規模及預測

2024 年核子造影設備市場規模為 28.6 億美元，預計到 2032 年將達到 40.3 億美元，2026 年至 2032 年的複合年成長率為 4.85%。

核子造影設備是指用於核子醫學觀察和評估體內器官和組織功能的專用醫療設備。這種成像技術使用少量放射性物質（稱為放射性藥物或放射性示踪劑），其發射伽馬射線，由機器檢測以創建圖像。

核成像設備旨在根據器官的生理功能（而不僅僅是其結構外觀）捕捉影像，並且不同於X光和電腦斷層掃描等傳統成像方式。

核子影像設備廣泛用於診斷多種疾病，包括癌症、心臟病等。核子造影設備使醫療保健提供者能夠監測器官功能並評估病情進展。

核子醫學掃描術診斷通常是非侵入性的、無痛的，這使其成為現代診斷中的有價值的工具。

核子造影設備的全球市場動態

影響全球核子造影設備市場的關鍵市場動態是：

關鍵市場促進因素

診斷程序的需求不斷增加：每年有超過 3,000 萬名患者使用核醫和分子成像技術進行診斷或治療，凸顯了對這些技術進行準確診斷和治療計劃的依賴性日益增強。

技術進步：SPECT/CT、PET/CT等先進影像技術的發展與融合，提升了診斷能力。核能總署(IAEA) 報告稱，全球已安裝超過 27,000 套 SPECT 系統和 5,200 套 PET 系統，顯示這些技術已被廣泛採用。

慢性病的增加：慢性病，尤其是癌症和心血管疾病的增加推動了對有效診斷的需求。核子醫學掃描術診斷在腫瘤學的診斷、分期和治療監測中起著重要作用，已成為現代醫學的重要組成部分。

支持性法規環境：美國美國核能管理委員會(NRC) 和食品藥物管理局(FDA) 等監管機構提供促進核子醫學攝影技術安全使用的指導方針。這種監管支持刺激了創新並鼓勵醫療機構投資新設備。

主要市場問題

遵守嚴格的規定：核子影像領域受到美國美國核能管理委員會(NRC) 和食品藥物管理局(FDA) 等機構的嚴格監管。這些規定要求嚴格遵守安全標準，包括設備校準和劑量記錄。 NRC 要求各設施定期進行區域調查，以確保輻射水平低於規定的閾值，這使醫療保健提供者的業務變得複雜。

資本成本高：PET 和 SPECT 掃描儀等核成像設備的初始投資和維護成本對於許多醫療機構來說過高，尤其是在發展中地區。這些經濟障礙限制了人們獲得先進診斷技術的機會，進而影響了整個市場。

技術的複雜性：核子成像技術的快速發展需要對醫務人員進行持續的培訓和教育。如果醫務人員沒有接受充分培訓，操作先進設備的複雜性可能會導致錯誤，從而危及患者的安全和診斷的準確性。

來自替代成像方式的競爭：非核成像技術，例如 MRI 和電腦斷層掃描，已經顯著提高了解析度，並且通常是醫療保健提供者有吸引力的選擇，這可能會減少核成像技術的市場佔有率。這些模式的廣泛採用可能會分散核成像領域的資金和注意力。

主要市場趨勢：

先進技術的整合：將人工智慧 (AI) 和機器學習整合到核成像系統（尤其是 SPECT 成像）中越來越流行。這種整合將增強影像分析，提高診斷準確性並增加業務效率。美國國立衛生研究院 (NIH) 正在積極資助該領域的研究，以透過先進的影像技術改善患者的治療效果。

混合影像系統：SPECT/CT 和 PET/CT 等混合影像系統的開發和採用正在增加。這些系統將核子醫學的功能性影像與電腦斷層掃描的解剖影像相結合，提供全面的診斷資訊。據核能（IAEA）稱，混合系統顯著提高了各個醫療領域的診斷準確性和定位性。

新型放射性藥物的出現：新型放射性藥物的引進正在擴大核子造影的應用。這些進步使得對特定疾病進行更有針對性的成像成為可能，並提高了診斷方法的有效性。美國食品藥物管理局（FDA）近年來核准了幾種新的放射性藥物，反映出該領域的創新日益增多。

關注病人安全：人們越來越重視在核子醫學影像檢查中減少病患的輻射暴露。 NRC 等監管機構提倡將輻射暴露保持在盡可能低的合理水平 (ALARA)，這是在不影響影像品質的情況下提高安全性的技術進步背後的驅動力。

Nuclear imaging equipment refers to specialized medical devices used in nuclear medicine to visualize and assess the function of organs and tissues within the body. This imaging technique utilizes small amounts of radioactive materials, known as radiopharmaceuticals or radiotracers, which emit gamma rays that are detected by the equipment to create images.

Nuclear imaging equipment is designed to capture images based on the physiological function of organs rather than just their structural appearance, distinguishing it from traditional imaging modalities like X-rays or CT scans.

Nuclear imaging equipment is widely used for diagnosing various conditions, including cancers, heart disease, and other It allows healthcare providers to monitor organ function and assess disease progression.

Nuclear imaging is generally non-invasive and painless, making it a valuable tool in modern diagnostics.

Global Nuclear Imaging Equipment Market Dynamics

The key market dynamics that are shaping the global nuclear imaging equipment market include:

Key Market Drivers:

Increasing Demand for Diagnostic Procedures: Over 30 million patients are diagnosed or treated annually using nuclear medicine and molecular imaging techniques, highlighting the growing reliance on these technologies for accurate diagnosis and treatment planning.

Advancements in Technology: The development and integration of advanced imaging technologies, such as SPECT/CT and PET/CT, have enhanced diagnostic capabilities. The International Atomic Energy Agency (IAEA) reports that over 27,000 SPECT systems and more than 5,200 PET systems are installed worldwide, indicating widespread adoption of these technologies.

Growing Prevalence of Chronic Diseases: The rise in chronic diseases, particularly cancers and cardiovascular disorders, drives the demand for effective diagnostic Nuclear imaging is critical in oncology for diagnosis, staging, and treatment monitoring, making it an essential component of modern healthcare.

Supportive Regulatory Environment: Regulatory bodies, such as the S. Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA), provide guidelines that facilitate the safe use of nuclear imaging technologies. This regulatory support fosters innovation and encourages healthcare facilities to invest in new equipment.

Key Market Challenges:

Stringent Regulatory Compliance: The nuclear imaging sector is subject to rigorous regulations imposed by bodies like the U.S. Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA). These regulations require strict adherence to safety standards, including calibration of equipment and documentation of administered dosages. The NRC mandates that facilities conduct regular area surveys to ensure radiation doses remain below specified thresholds, complicating operational procedures for healthcare providers.

High Equipment Costs: The initial investment and maintenance costs for nuclear imaging equipment, such as PET and SPECT scanners, can be prohibitively high for many healthcare facilities, especially in developing regions. This financial barrier limits access to advanced diagnostic technologies, impacting overall market

Technological Complexity: The rapid advancements in nuclear imaging technology necessitate continuous training and education for medical staff. The complexity of operating sophisticated equipment can lead to errors if personnel are not adequately trained, which can compromise patient safety and diagnostic accuracy.

Competition from Alternative Imaging Modalities: Non-nuclear imaging techniques, such as MRI and CT scans, have seen significant advancements in resolution and These alternatives often provide compelling options for healthcare providers, leading to potential market share loss for nuclear imaging technologies. The increasing adoption of these modalities can divert funding and attention away from nuclear imaging.

Key Market Trends:

Integration of Advanced Technologies: There is a growing trend towards integrating artificial intelligence (AI) and machine learning into nuclear imaging systems, particularly in SPECT imaging. This integration enhances image analysis, improves diagnostic accuracy, and increases operational efficiency. The National Institutes of Health (NIH) is actively funding research in this area to improve patient outcomes through advanced imaging techniques.

Hybrid Imaging Systems: The development and adoption of hybrid imaging systems, such as SPECT/CT and PET/CT, are on the rise. These systems combine functional imaging from nuclear medicine with anatomical imaging from CT scans, providing comprehensive diagnostic information. According to the International Atomic Energy Agency (IAEA), hybrid systems have significantly improved diagnostic accuracy and localization in various medical fields.

Emergence of New Radiopharmaceuticals: The introduction of novel radiopharmaceuticals is expanding the applications of nuclear imaging. These advancements allow for more targeted imaging of specific diseases, enhancing the effectiveness of diagnostic procedures. The U.S. Food and Drug Administration (FDA) has approved several new radiotracers in recent years, reflecting the ongoing innovation in this area.

Focus on Patient Safety: There is an increasing emphasis on reducing radiation exposure to patients during nuclear imaging procedures. Regulatory bodies like the NRC advocate for practices that keep radiation doses as low as reasonably achievable (ALARA), which is driving technological advancements aimed at improving safety without compromising image quality.

Global Nuclear Imaging Equipment Market Regional Analysis

Here is a more detailed regional analysis of the global nuclear imaging equipment market:

North America:

North America accounted for approximately 42% of the global nuclear imaging equipment market in 2023. This significant share reflects the region's advanced healthcare infrastructure and high demand for diagnostic imaging

The region faces a growing incidence of chronic diseases, particularly cancer and cardiovascular The International Agency for Research on Cancer projects that by 2025, the worldwide cancer prevalence will reach over 50 million, driving the need for effective diagnostic tools like nuclear imaging.

North America is at the forefront of technological advancements in nuclear imaging, including the development of hybrid systems like SPECT/CT and PET/CT. These innovations enhance diagnostic accuracy and are supported by funding from organizations such as the National Institutes of Health (NIH), which promotes research in advanced imaging techniques.

The increasing elderly population in North America contributes to a higher demand for diagnostic procedures. As older adults are more susceptible to chronic diseases requiring regular monitoring, this demographic trend further fuels the growth of nuclear imaging services.

Europe:

Europe is expected to account for a substantial portion of the global nuclear imaging equipment market, driven by a high number of product launches and advancements in technology. For instance, the region's market share is projected to grow significantly due to innovations from companies like Siemens Healthineers and Philips

The European Medicines Agency (EMA) and national regulatory bodies enforce stringent regulations that ensure high safety and efficacy standards for nuclear imaging This regulatory environment fosters innovation while ensuring patient safety.

The rise in chronic diseases, particularly cancer and cardiovascular conditions, is a significant driver of demand for nuclear imaging. According to the World Health Organization (WHO), cancer was responsible for approximately 1 in 6 deaths globally in 2020, highlighting the need for effective diagnostic tools.

The aging population in Europe is driving demand for diagnostic imaging services. By 2030, it is estimated that over 25% of the EU population will be over 65 years old, increasing the prevalence of age-related diseases that require advanced imaging

Global Nuclear Imaging Equipment Market: Segmentation Analysis

The Global Nuclear Imaging Equipment Market is Segmented based on Product, Application, End-User, And Geography.

Nuclear Imaging Equipment Market, By Product

SPECT Imaging Systems
PET Imaging Systems
Planar Scintigraphy Imaging Systems

Based on Product, the global Nuclear Imaging Equipment market is divided into SPECT Imaging Systems, PET Imaging Systems, and Planar Scintigraphy Imaging Systems. SPECT imaging systems hold a significant share of the nuclear imaging market, driven by their widespread use in various diagnostic applications, including cardiology, oncology, and neurology. The global SPECT market is projected to grow from approximately $2.1 billion in 2022 to $4.7 billion by 2032, reflecting a robust CAGR of 8.5% during this period.

Nuclear Imaging Equipment Market, By Application

Oncology
Cardiology
Neurology

Based on Application, the market is segmented into Oncology, Cardiology, and Neurology. The oncology segment is expected to account for a significant portion of the nuclear imaging equipment market, with estimates indicating it held over 49% of the market share in 2022. This dominance is driven by the rising incidence of cancer globally, necessitating advanced diagnostic tools for effective detection and treatment planning.

Nuclear Imaging Equipment Market, By End-User

Hospitals
Imaging Centers
Academic & Research Centers

Based on End-User, the market is fragmented into Hospitals, Home Care Settings, Ambulatory Surgery Centers, and Laboratories and Clinics. The hospitals segment accounted for over 52.75% of the nuclear imaging equipment market in 2023. This significant share reflects the extensive use of nuclear imaging technologies in hospital settings for various diagnostic procedures.

Nuclear Imaging Equipment Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on Geography, the Global Nuclear Imaging Equipment Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for approximately 42% of the global nuclear imaging equipment market in 2023. This significant share reflects the region's advanced healthcare infrastructure and high demand for diagnostic imaging technologies.

Key Players

The "Global Nuclear Imaging Equipment Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, Absolute Imaging, Inc., pectrum Dynamics, CMR Naviscan., TTG Imaging Solutions, Lucero Dynamics, Berthold Technologies GmbH & COKG, and Siemens Healthineers. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above- mentioned players globally.

Nuclear Imaging Equipment Market Recent Developments
In March 2023, Digirad Corporation launched its nSPEED 3D reconstruction software, which enhances imaging speed and reduces patient dosing This software is part of Digirad's commitment to advancing nuclear imaging technology and improving patient comfort.
In April 2023, Canon Medical Systems introduced the Cartesion Prime Digital PET- CT system, which features advanced AI technology for enhanced image quality and speed. This system is designed to improve disease pathology assessment and facilitate tailored treatment approaches.

1 INTRODUCTION OF GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT

5.1 Overview
5.2 SPECT Systems
5.3 Hybrid PET Systems
5.4 Planar Scintigraphy

6 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION

6.1 Overview
6.2 Oncology
6.3 Cardiology
6.4 Neurology
6.5 Others

7 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Imaging Centers
7.4 Academic and Research Centers
7.5 Others

8 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Siemens AG
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 GE Healthcare
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Philips Healthcare
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Digirad Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Surgiceye GmbH
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments